| Martin J Voss, MD | |
|
733 W Clairemont Ave, Eau Claire, WI 54701-6101 | |
| (715) 838-5222 | |
| Not Available |
| Full Name | Martin J Voss |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology |
| Location | 733 W Clairemont Ave, Eau Claire, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750353900 | NPI | - | NPPES |
| 30398900 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 23287 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Martin J Voss, MD Po Box 1510, Eau Claire, WI 54702-1510 Ph: (715) 838-5222 | Martin J Voss, MD 733 W Clairemont Ave, Eau Claire, WI 54701-6101 Ph: (715) 838-5222 |
News Archive
The American Gastroenterological Association, in partnership with the Crohn's & Colitis Foundation of America and Janssen Biotech, Inc., announced today that Theresa Alenghat, VMD, PhD, from Cincinnati Children's Hospital Medical Center, OH, was awarded with the 2015 AGA-CCFA-Janssen Research Award in Inflammatory Bowel Disease (IBD) Epigenetics Research.
Burnham Institute for Medical Research (Burnham) announced today that philanthropist T. Denny Sanford has pledged $50 million to support and further expand and accelerate the Institute's leading-edge medical research. To honor Sanford, Burnham, has been renamed the Sanford-Burnham Medical Research Institute. This is the second gift Sanford has made to Burnham. In 2007, he directed $20 million through Sanford Health to create the Sanford Children's Health Research Center at Burnham.
Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has secured $10 million in investments from high net-worth individuals and institutions. This round of investment, which closed six months ahead of the company's year-end goal, will provide ACT additional capital to continue its development and commercialization of potentially lifesaving therapeutics for cancer patients.
New data suggest that the transcription factor FOXO3 may protect against alcohol-induced liver injury. Researchers determined that alcohol given to mice deficient in FOXO3 caused severe liver injury resembling human alcoholic hepatitis.
› Verified 5 days ago
Barry J Rhodes, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 733 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-838-5222 | |
Adela Virginia Taylor, M. D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 733 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-838-5222 |